English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

To estimate the levels of serum IgE that is actually able to be bound to FcεRI, we developed a novel enzyme-linked immunosorbent assay (ELISA) using a recombinant soluble form of the human FcεRIα ectodomain (soluble α-ELISA). We evaluated the levels of FcεRI-bindable serum IgE in normal volunteers and in patients with atopic dermatitis and bronchial asthma, and compared them with those of total IgE measured by a conventional sandwich-ELISA. There was a striking difference between the IgE values evaluated with these two ELISA systems. In most of the sera, the IgE values evaluated with the soluble α-ELISA were substantially lower than those evaluated with the sandwich-ELISA. Our results indicate that all serum IgE (especially in hyper-lgE sera) does not necessarily bind to the FcεRI and that it will be useful to evaluate FcεRI-bindable IgE for further analysis of allergic states

Evaluation of FcεRI-Bindable Human Ige With an Enzyme-Linked Immunosorbent Assay Using a Recombinant Soluble form of the Human FcεRIα Ectodomain